GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunho Biologics Inc (HKSE:02898) » Definitions » Dividend Yield %

Sunho Biologics (HKSE:02898) Dividend Yield % : 0.00% (As of Mar. 29, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Sunho Biologics Dividend Yield %?

As of today (2025-03-29), the Trailing Annual Dividend Yield of Sunho Biologics is 0.00%.

The historical rank and industry rank for Sunho Biologics's Dividend Yield % or its related term are showing as below:

HKSE:02898's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.4
* Ranked among companies with meaningful Dividend Yield % only.

Sunho Biologics's Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00.

As of today (2025-03-29), the Forward Dividend Yield % of Sunho Biologics is 0.00%.

Sunho Biologics's Dividends per Share for the six months ended in Jun. 2024 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Sunho Biologics Dividend Yield % Historical Data

The historical data trend for Sunho Biologics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunho Biologics Dividend Yield % Chart

Sunho Biologics Annual Data
Trend Dec22 Dec23
Dividend Yield %
- -

Sunho Biologics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
Dividend Yield % - - - -

Competitive Comparison of Sunho Biologics's Dividend Yield %

For the Biotechnology subindustry, Sunho Biologics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunho Biologics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunho Biologics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Sunho Biologics's Dividend Yield % falls into.


;
;

Sunho Biologics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Sunho Biologics  (HKSE:02898) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Sunho Biologics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Sunho Biologics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunho Biologics Business Description

Traded in Other Exchanges
N/A
Address
No. 198 Peninsula Middle Road, Dipu Street, Room 302, Building 3, Anji County, Zhejiang Province, Huzhou, CHN
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
Executives
Sunho Fortune Investments Limited 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Zhang Feng 2201 Interest of corporation controlled by you
Sunho Wisdom Investments Limited 2101 Beneficial owner

Sunho Biologics Headlines

No Headlines